BIO's Policy Pulse: BIO Vice Chair John Crowley to Congress: IRA Reduces Access to Innovative Drugs

tradeshow-related-video
Oct 03
Share post

John Crowley, CEO of Amicus Therapeutics and Vice Chair of the Board of the Biotechnology Innovation Organization (BIO), told Congress that drug price controls in the Inflation Reduction Act (IRA) harm the development of new drugs, as he testified before the House Energy & Commerce Oversight and Investigations Subcommittee on Sept. 20, 2023.
Bio.News: https://bio.news/latest-news/bio-board-vice-chair-crowley-tells-congress-ira-reduces-access-to-innovative-drugs/

source

https://www.bio.org/events/bio-international-convention